Siemens Installs First of SPECT/ PET/CT Line

The University of Wisconsin Comprehensive Cancer Center is the first site in the U.S. to install Siemens’ Inveon, a PET, SPECT and CT hybrid-imaging device, which researchers at the university hope will allow them to better visualize and characterize disease.
Inveon’s modular design allows users to image individually or with all three modalities in combination. The system is instrumental for imaging molecular biomarkers enabling the identification of disease pathways, evaluation of disease progress, tracking response to novel therapies and may speed drug development.
“The Inveon establishes and delivers the physical limits of PET and CT imaging, pushing researchers to develop molecular imaging agents that are capable of capitalizing on its incredible resolution and sensitivity. Within hours of receiving the system, we were able to set up and acquire the first preclinical images,” said James Weichert, Ph.D., associate professor of Radiology, University of Wisconsin School of Medicine and Public Health.